Smartleaf Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Hold
3,019
0.01% 807
2026
Q1
$187K Buy
3,019
+678
+29% +$47.2K 0.01% 810
2025
Q4
$157K Buy
2,341
+366
+19% +$23.7K 0.01% 932
2025
Q3
$131K Buy
1,975
+988
+100% +$78.2K 0.01% 926
2025
Q2
$85.2K Sell
987
-410
-29% -$32.1K 0.01% 923
2025
Q1
$94.6K Buy
1,397
+109
+8% +$8.89K 0.01% 857
2024
Q4
$100K Buy
1,288
+108
+9% +$8K 0.01% 843
2024
Q3
$79.4K Buy
1,180
+530
+82% +$43.5K 0.01% 779
2024
Q2
$74.5K Buy
650
+295
+83% +$37.3K 0.01% 646
2024
Q1
$49.5K Buy
355
+172
+94% +$21.6K 0.01% 676
2023
Q4
$22.7K Buy
+183
New +$18.7K 0.01% 653

Other funds holding DXCM

Smartleaf Asset Management's DXCM Position: Q2 2026 in Review

Smartleaf Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 3,019 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #807.

Smartleaf Asset Management first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Smartleaf Asset Management held 3,019 shares of DexCom worth $211K as of Q2 2026.
  • Smartleaf Asset Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #807 holding.
  • Smartleaf Asset Management first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.